After years of manufacturing woes torpedoed their chances to challenge Sanofi's blockbuster insulin injection Lantus, Mylan and Biocon recently received the FDA's go-ahead to launch their knockoff.

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- and long-acting insulins.

The product site for Sanofi-Aventis’s insulin injection Lantus received the highest mark in terms of consumer satisfaction, according to a Manhattan Research study. The website (which features ...

GoodRx, a resource for healthcare savings and information, is working with Sanofi, a company that specializes in diabetes care, to offer people living with diabetes access to Lantus (insulin glargine ...

PARIS, France, June 9, 2012-- Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that people with early type 2 diabetes uncontrolled on metformin demonstrated superior HbA1c - glycated hemoglobin ...

Share on Pinterest Semglee is an alternative for people with diabetes who now use long-acting injectable insulin products such as Lantus. Getty Images The Food and Drug Administration (FDA) has ...

The product site for Sanofi-Aventis’s insulin injection Lantus received the highest mark in terms of consumer satisfaction, according to a Manhattan Research study. The site (which features optional ...